Meet The Team
Mary Schaheen
Mary Schaheen is an accomplished business executive with deep experience in integration and product commercialization spanning 25 years in business, 15 as a senior executive. Mary has served as the Chairman of Prevail InfoWorks Inc. since 2007. She has grown Prevail InfoWorks, Inc. into a global life sciences company and was integral to the creation of Prevail Partners. Under Mary's direction, Prevail Partners has made strategic investing painless to further portfolio companies’ product commercialization goals.
Recognized for her expertise in the life sciences industry, Mary has cultivated, with Prevail, over 3000 C-level and senior contacts among life science companies. She lectures extensively, most recently as keynote speaker, where she was highlighting exit opportunities, at a private meeting for CEOs.
President and Director
Prior to joining Prevail Partners, Patrick was in private law practice for over 20 years. One of his areas of practice was in intellectual property law. While in private practice, Patrick was listed multiple times among Pennsylvania Super Lawyers. He completed his B.A. with honors from Stockton University and received his Juris Doctorate from Rutgers School of Law. Patrick is also a graduate of the Temple University Academy of Trial Advocacy. He is a board member of the non-profit Peace of Mind Project and Shimojani Inc.
Patrick Keenan
Managing Director
Advisory Board
Lester Crawford, MD
Dr. Crawford is the former Commissioner of the United States Food and Drug Administration (FDA). Previously, Dr. Crawford was Chair of the Department of Physiology-Pharmacology at the University of Georgia, Administrator of the Food Safety and Inspection Service (USDA) and Deputy Commissioner of FDA. From 1997-2002, he was Director of the Center for Food and Nutrition Policy at Georgetown University and at Virginia Tech. Dr. Crawford also served as Administrator of the Food Safety and Inspection Service (United States Department of Agriculture) from 1987 to 1991 as well as director of the FDA's Center for Veterinary Medicine from 1978 to 1980, and again from 1982 to 1985.
Stefan Loren, Ph.D., Westwicke Partners
Wall Street experience, both the buy- and sell-sides. Analyst/Portfolio Manager with hedge fund, Perceptive Advisors and MTB investment Advisors in biotech, specialty pharma, life science-tools, health care service and chemistry outsourcing. Managing Director, Legg Mason. His "Select List" picks returned an average 118% upside, and beat the Nasdaq Biotechology and S&P indicies in 6 of 6 years. At Abbott Laboratories Advanced Technologies Division, integrated new technological advances. At Scripps Research Institute, worked with Nobel Laureate K. Barry Sharpless. Received a doctorate in Organic/Pharm. Chemistry from the UC Berkeley and a B.S. degree in Chemistry from UCSD. Featured in Scientific American, Time, Newsweek, Discover as well as other periodicals and journals.
Todd Plott, MD
Involved in 9 different development programs that have received approval by the U.S. Food and Drug Administration (FDA) and other international regulatory agencies. Five of these programs were personally led and supervised by Dr. Plott from initiation through approval. Former CMO at Revance Therapeutics; VP Clinical Research and Regulatory Affairs at Medicis Pharmaceuticals; Director at Schering-Plough.
In Memory,
Jordan Schreiber, CFA
Mr. Schreiber has more than 30 years of investment experience. In addition to being a Chartered Financial Analyst, Mr. Schreiber holds an MBA from Harvard Business School and a Ph.D. from New York University. He is a member of the New York Society of Security Analysts and a member and former president of the Health Care Analyst Group of New York. Mr. Schreiber has led the portfolio management team of the Merrill Lynch Healthcare Fund since 1990. Prior to 1990, he co-managed that fund's predecessor, the Merrill Lynch SCI/TECH Fund.